Instructions for the Moderna Spikevax TM bivalent vaccine (BA.1/BA.4-5), covering efficacy, administration, contraindications, and adverse reactions for…
This document provides instructions for the Moderna Spikevax TM bivalent vaccine, which targets the original strain and Omicron variants BA.1 or BA.4-5. It is intended for booster doses starting in spring 2023 for individuals aged 12 and older who have completed their initial vaccination series. The vaccine is administered via intramuscular injection and is covered by public funding in Japan. This manual is written in Chinese.
| Vaccine Type | mRNA vaccine |
|---|---|
| Dose Volume | 0.5mL |
| Minimum Interval | 3 months |
| Active Ingredients | Elasomeran, Imelasomeran or Davesomeran |
Eligible groups include those aged 65 and older, individuals aged 12-64 with underlying conditions, and healthcare workers.
No, this vaccine cannot be used for the initial vaccination.
Main reactions include pain at the injection site, headache, joint and muscle pain, fatigue, chills, and fever.
Wait at least 15 minutes; wait 30 minutes if there is a history of severe allergic reactions.